The first novel coronavirus vaccine tests begin in Seattle. The vaccine, produced by Moderna Inc, will be given to 45 volunteers in order to determine if it produces harmful side effects.
Even if the testing goes well, it may be at least a year away from a publicly-available vaccine against COVID-19.
These human trials, which were originally expected to begin this summer before being fast-tracked due to the growing pandemic, are the first step toward a publicly available vaccine. However, even if the trials prove the experimental vaccine is safe and effective, it will still be many months before it can be mass-produced and distributed.
17-03-2020 PANORAMAdailyGIBRALTAR